Immune Backup System

For this article, Karen Young Kreeger interviewed Joseph H. Phillips, senior staff scientist at DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, Calif. DNAX is a private research center funded by Schering-Plough. Data from the Web of Science (ISI, Philadelphia) show that this paper has been cited significantly more often than the average paper of the same type and age. V.M. Braud, D.S.J. Allan, C.A. O'Callaghan, K. Soderstrom, A.D. Andrea, G.S. Ogg, S. Lazetic, N.T. Young

Written byKaren Young Kreeger
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

For this article, Karen Young Kreeger interviewed Joseph H. Phillips, senior staff scientist at DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, Calif. DNAX is a private research center funded by Schering-Plough. Data from the Web of Science (ISI, Philadelphia) show that this paper has been cited significantly more often than the average paper of the same type and age. V.M. Braud, D.S.J. Allan, C.A. O'Callaghan, K. Soderstrom, A.D. Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, L.L. Lanier, and A.J. McMichael, "HLA-E binds to natural killer cell receptors CD94/NKG2A, B, and C," Nature, 391:795-9, 1998. (Cited in about 183 papers since publication) The way the immune system responds to pathogens and distinguishes self from nonself is complex. For many years researchers thought that major histocompatibility complex (MHC) class I molecules, cell surface proteins that present unique host antigens, were the only way that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies